Patents by Inventor Edna Bechor

Edna Bechor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9326998
    Abstract: The invention relates to the use of viral inactivated-plasma cryoprecipitate concentrate (VIPCC) comprising a suitable fibronactin/fibrinogen ratio for treating a spine disease, disorder or condition such as intervertebral disc degeneration.
    Type: Grant
    Filed: January 7, 2015
    Date of Patent: May 3, 2016
    Assignee: Omrix Biopharmaceuticals Ltd.
    Inventors: Israel Nur, Liliana Bar, Edna Bechor
  • Publication number: 20150196596
    Abstract: The invention relates to the use of viral inactivated-plasma cryoprecipitate concentrate (VIPCC) comprising a suitable fibronactin/fibrinogen ratio for treating a spine disease, disorder or condition such as intervertebral disc degeneration.
    Type: Application
    Filed: January 7, 2015
    Publication date: July 16, 2015
    Inventors: Israel Nur, Liliana Bar, Edna Bechor
  • Patent number: 8968724
    Abstract: The invention relates to the use of viral inactivated-plasma cryoprecipitate concentrate (VIPCC) comprising a suitable fibronectin/fibrinogen ratio for treating a spine disease, disorder or condition such as intervertebral disc degeneration.
    Type: Grant
    Filed: August 29, 2008
    Date of Patent: March 3, 2015
    Assignee: Omrix Biopharmaceuticals Ltd.
    Inventors: Edna Bechor, Liliana Bar, Israel Nur
  • Publication number: 20100310524
    Abstract: The invention relates to the use of viral inactivated-plasma cryoprecipitate concentrate (VIPCC) comprising a suitable fibronectin/fibrinogen ratio for treating a spine disease, disorder or condition such as intervertebral disc degeneration.
    Type: Application
    Filed: August 29, 2008
    Publication date: December 9, 2010
    Inventors: Edna Bechor, Liliana Bar, Israel Nur